262.21MMarket Cap-0.80P/E (TTM)
3.135High2.865Low718.83KVolume2.980Open3.000Pre Close2.16MTurnover1.27%Turnover Ratio4.37P/E (Static)85.69MShares19.42052wk High1.34P/B172.98MFloat Cap1.57552wk Low--Dividend TTM56.53MShs Float41.930Historical High--Div YieldTTM9.00%Amplitude1.575Historical Low3.009Avg Price1Lot Size
Amylyx Pharmaceuticals Stock Forum
Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis
Amylyx Pharmaceuticals (NASDAQ: AMLX) announced that the FDA has lifted the clinical hold on its Phase 1 clinical trial of AMX0114, an antisense oligonucleotide targeting calpain-2 for ALS treatment. The company will proceed with opening U.S. sites for screening, enrollment, and dosing.
The Phase 1 LUMINA cl...
No comment yet